Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists

Journal of Pharmacology and Experimental Therapeutics

Volumn 290, Issue 3, 1999, Pages 1065-1079

  Martin, Billy R ^a   Jefferson, R ^a   Winckler, R ^a   Wiley, J L ^a   Huffman, J W ^b   Crocker, P J ^b   Saha, B ^c   Razdan, R K ^c  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CLEMSON UNIVERSITY   (United States)

^c ORGANIX INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID RECEPTOR; TETRAHYDROCANNABINOL; TETRAHYDROCANNABINOL DERIVATIVE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CHEMICAL BOND; DRUG ACTIVITY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

ANIMALS; KINETICS; MALE; MICE; MICE, INBRED ICR; MOLECULAR CONFORMATION; PSYCHOTROPIC DRUGS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; STRUCTURE-ACTIVITY RELATIONSHIP; TETRAHYDROCANNABINOL;

EID: 0032812926     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Busch-Petersen J, Hill WA, Fan P, Khanolkar A, Xie X, Tius MA and Makriyannis A (1996) Unsaturated side chain β-11-hydroxyhexahydrocannabinol analogs. J Med Chem 39:3790-3796.
2. 9-THC analogs. Pharmacol Biochem Behav 40:509-512.
3. 8-THC: A novel photoaffinity label for cannabinoid receptor. J Med Chem 35:3076-3079.
4. 9-tetrahydrocannabinol. J Pharmacol Exp Ther 263:1118-1126.
5. Compton DR, Johnson MR, Melvin LS and Martin BR (1992b) Pharmacological profile of a series of bicyclic cannabinoid analogs: Classification as cannabimimetic agents. J Pharmacol Exp Ther 260:201-209.
6. Compton DR, Rice KC, De Costa BR, Razdan RK, Melvin LS, Johnson MR and Martin BR (1993) Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther 285:218-226.
7. Devane WA, Dysarz FA, Johnson MR, Melvin LS and Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605-613.
8. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A and Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949.
9. Dewey WL (1986) Cannabinoid pharmacology. Pharmacol Rev 38:151-178.
10. Dewey WL, Harris LS, Howes JF and Nuite JA (1970) The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. J Pharmacol Exp Ther 176:435-442.
11. 8 linkage to the CB1 receptor. J Neurosci 17:5327-5333.
12. Griffin G, Wray EJ, Rorrer WK, Crocker PJ, Ryan WJ, Saha B, Razdan RK, Martin BR and Abood ME (1999) An investigation into the structural determinants of cannabinoid receptor ligand efficacy. Br J Pharmacol 128:1575-1584.
13. Howlett AC (1984) Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds. Life Sci 36:1803-1810.
14. Howlett AC and Fleming RM (1984) Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. Mol Pharmacol 26:532-538.
15. Howlett AC, Johnson MR, Melvin LS and Milne GM (1988) Nonclassical cannabinoid analgetics inhibit adenylate cyclase: Development of a cannabinoid receptor model. Mol Pharmacol 33:297-302.
16. 8-tetrahydrocannabinol. Pharmacol Biochem Behav 32: 661-666.
17. Loev B, Bender PE, Dowalo F, Macko E and Fowler PJ (1973) Cannabinoids: Structure-activity studies related to 1,2-dimethylheptyl derivatives. J Med Chem 16:1200-1206.
18. Mackie K and Hille B (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci USA 89:3825-3829.
19. 9-THC. Pharmacol Biochem Behav 46:295-301.
20. Martin BR, Compton DR, Little PJ, Martin TJ and Beardsley PM (1987) Pharmacological evaluation of agonistic and antagonistic activity of Cannabinoids, in Structure-Activity Relationships of Cannabinoids (Rapaka RS and Makriyannis A eds) pp 108-122, U.S. Government Printing Office, Washington, DC
21. McOmie JFW and West DE (1973) 3,3′-Dihydroxybiphenyl, in Organic Syntheses Collective (Baumgarten HE ed) vol 5, pp 412-414, John Wiley & Sons, Inc., New York.
22. Mechoulam R and Edery H (1973) Structure-activity relationships in the cannabinoid series, in Marijuana: Chemistry, Pharmacology, Metabolism, and Clinical Effects (Mechoulam R ed) pp 101-136, Academic Press, New York.
23. Melvin L, Milne G, Johnson M, Subramaniam B, Wilken G and Howlett A (1993) Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: Studies of bicyclic cannabinoid analogs. Mol Pharmacol 44:1008-1015.
24. Pacheco M, Childers SR, Arnold R, Casiano F and Ward SJ (1991) Aminoalkylindoles: Actions on specific G-protein-linked receptors. J Pharmacol Exp Ther 257:170-183.
25. 8-tetrahydrocannabinol in two isolated tissue preparations. Eur J Pharmacol 315: 195-201.
26. Razdan RK (1986) Structure-activity relationships in cannabinoids. Pharmacol Rev 38:75-149.
27. 1-tetraydrocannabinol (THC) from p-mentha-2,8-dien-1-ol and olivetol. J Am Chem Soc 96:5860.
28. 8-tetrahydrocannabinol with potent biological activity. J Med Chem 19:1328-1330.
29. Reggio PH, McGaughey GB, Odear DF, Seltzman HH, Compton DR and Martin BR (1991) A rational search for the separation of psychoactivity and analgesia in cannabinoids. Pharmacol Biochem Behav 40:479-486.
30. 9-THCS. Life Sci 56:2013-2020.
31. Ryan WJ, Banner WK, Wiley JL, Martin BR and Razdan RK (1997) Potent anandamide analogs: The effect of changing the length and branching of the end pentyl chain. J Med Chem 40:3617-3625.
32. Seltzman HH, Fleming DN, Thomas BF, Gilliam AF, McCallion DS, Pertwee RG, Compton DR and Martin BR (1997) Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide. J Med Chem 40:3626-3634.
33. 8-tetrahydrocannabinol. J Med Chem 41:4400-4407.
34. Smith PB, Compton DR, Welch SP, Razdan RK, Mechoulam R and Martin BR (1994) The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J Pharmacol Exp Ther 270:219-227.
35. Thomas BF, Adams IB, Mascarella SW, Martin BR and Razdan RK (1996) Structure-activity analysis of anandamide analogs: Relationship to a cannabinoid pharmacophore. J Med Chem 39:471-479.
36. Thomas BF, Compton DR, Martin BR and Semus SF (1991) Modeling the cannabinoid receptor: A three-dimensional quantitative structure-activity analysis. Mol Pharmacol 40:656-665.
37. Wiley JL, Compton DR, Dai D, Lainton JAH, Phillips M, Huffman JW and Martin BR (1998) Structure-activity relationships of indole- and pyrrole-derived cannabinoids. J Pharmacol Exp Ther 285:995-1004.